Megan J Dailey

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Nutrient specific feeding and endocrine effects of jejunal infusions
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Obesity (Silver Spring) 18:904-10. 2010
  2. ncbi Inositol polyphosphate multikinase: an emerging player for the central action of AMP-activated protein kinase
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Biochem Biophys Res Commun 421:1-3. 2012
  3. ncbi Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Am J Physiol Endocrinol Metab 301:E1184-90. 2011
  4. ncbi Disassociation between preprandial gut peptide release and food-anticipatory activity
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 618, Baltimore, Maryland 21205, USA
    Endocrinology 153:132-42. 2012
  5. ncbi Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain
    Anutosh Chakraborty
    The Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Cell 143:897-910. 2010
  6. ncbi Minireview: Gut peptides: targets for antiobesity drug development?
    Timothy H Moran
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Endocrinology 150:2526-30. 2009
  7. ncbi Intestinal feedback signaling and satiety
    Timothy H Moran
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Ross 618, 720 Rutland Ave, Baltimore, MD 21205, United States
    Physiol Behav 105:77-81. 2011
  8. ncbi Glucagon-like peptide 1 and appetite
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Trends Endocrinol Metab 24:85-91. 2013

Collaborators

  • Nicholas T Bello
  • Solomon H Snyder
  • Timothy H Moran
  • Anutosh Chakraborty
  • Alex S Huang
  • James J Potter
  • Michael A Koldobskiy
  • David Maag
  • Esteban Mezey
  • Krishna R Juluri
  • Seyun Kim
  • Micah Maxwell
  • Adele M Snowman
  • Masoumeh Saleh

Detail Information

Publications8

  1. ncbi Nutrient specific feeding and endocrine effects of jejunal infusions
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Obesity (Silver Spring) 18:904-10. 2010
    ..Thus, particular nutrients are more effective at producing decreases in food intake, body weight, and inducing changes in peptide levels and could lead to a novel therapy for obesity...
  2. ncbi Inositol polyphosphate multikinase: an emerging player for the central action of AMP-activated protein kinase
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Biochem Biophys Res Commun 421:1-3. 2012
    ..Here we review and discuss a novel role for the hypothalamic IPMK signaling in the control of AMPK and central energy homeostasis...
  3. ncbi Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Am J Physiol Endocrinol Metab 301:E1184-90. 2011
    ..Whether increased secretion of additional gut peptides is also necessary for such suppressions remains to be determined...
  4. ncbi Disassociation between preprandial gut peptide release and food-anticipatory activity
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 618, Baltimore, Maryland 21205, USA
    Endocrinology 153:132-42. 2012
    ..These data suggest that separate mechanisms may underlie the preprandial increases in ghrelin and GLP-1 and changes in FAA, insulin, and glucose...
  5. ncbi Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain
    Anutosh Chakraborty
    The Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Cell 143:897-910. 2010
    ..IP6K1 knockout mice manifest insulin sensitivity and are resistant to obesity elicited by high-fat diet or aging. Inhibition of IP6K1 may afford a therapeutic approach to obesity and diabetes...
  6. ncbi Minireview: Gut peptides: targets for antiobesity drug development?
    Timothy H Moran
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Endocrinology 150:2526-30. 2009
    ..Whether any individual approach will have significant long-term efficacy remains to be demonstrated. Approaches that target multiple systems may hold the most promise...
  7. ncbi Intestinal feedback signaling and satiety
    Timothy H Moran
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Ross 618, 720 Rutland Ave, Baltimore, MD 21205, United States
    Physiol Behav 105:77-81. 2011
    ..Thus, gut peptides are clear targets for future obesity therapeutic developments...
  8. ncbi Glucagon-like peptide 1 and appetite
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Trends Endocrinol Metab 24:85-91. 2013
    ..Understanding the mechanisms underlying the appetite-suppressive effects of GLP-1 may help in developing targeted treatments for obesity...